BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 300 shares, a decrease of 76.9% from the February 28th total of 1,300 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is presently 0.1 days.

BioSyent Price Performance

Shares of BioSyent stock opened at $7.88 on Thursday. BioSyent has a 1 year low of $5.93 and a 1 year high of $8.90. The firm has a fifty day moving average price of $7.71 and a 200 day moving average price of $7.89.

BioSyent Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, March 3rd were issued a $0.0347 dividend. This represents a dividend yield of 1.77%. The ex-dividend date of this dividend was Friday, February 28th. This is a boost from BioSyent’s previous dividend of $0.03.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.